Follow-up Routines Matter for Adherence to Endocrine Therapy in the Adjuvant Setting of Breast Cancer [0.03%]
乳腺癌辅助内分泌治疗中坚持治疗的随访模式很重要
Carolina Aurell,Alaa Haidar,Daniel Giglio
Carolina Aurell
Background: Endocrine therapy (ET) adherence leads to increased survival in breast cancer (BC). How follow-up should be done to maximize adherence is not known. ...
MicroRNA-190b Targets RFWD3 in Estrogen Receptor-Positive Breast Cancer [0.03%]
microRNA-190b在雌激素受体阳性乳腺癌中靶向RFWD3基因
Elisabet Alexandra Frick,Karen Kristjansdottir,Snaedís Ragnarsdottir et al.
Elisabet Alexandra Frick et al.
Background: In the year 2020, breast cancer was the most common form of cancer worldwide. Roughly 70% of breast cancers are estrogen receptor-positive (ER+). MicroRNA-190b (miR-190b) has previously been reported to be upr...
Tissue Engineering Scaffolds Loaded With a Variety of Plant Extracts: Novel Model in Breast Cancer Therapy [0.03%]
负载各种植物提取物的组织工程支架：乳腺癌治疗中的新型模型
Reyhaneh Azhari Rad,Yasaman Naghdi,Mobina Majidi Jamalabadi et al.
Reyhaneh Azhari Rad et al.
Despite recent improvements in detecting and managing breast cancer (BC), it continues to be a major worldwide health concern that annually affects millions of people. Exploring the anti-BC potentials of natural compounds has received a lot...
Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging Therapeutic Options [0.03%]
HER2阳性转移性乳腺癌的标准治疗和新兴治疗方法选项
Sarah K Premji,Ciara C O&#x;Sullivan
Sarah K Premji
Prior to the advent of the HER2-targeted monoclonal antibody trastuzumab, HER2+ breast cancer (BC) was considered an aggressive disease with a poor prognosis. Over the past 25 years, innovations in molecular biology, pathology, and early th...
Clinicopathological Features and Treatment Outcomes of Male Breast Cancer in Pakistani Population: A 10-Year Retrospective Cross-Sectional Study [0.03%]
巴基斯坦男性乳腺癌的临床病理特征及治疗结果的十年回顾性横断面研究
Ibtissam Bin Khalid,Albash Sarwar,Hassham Bin Khalid et al.
Ibtissam Bin Khalid et al.
Background: Male breast cancer (MBC) accounts for 1% of global breast cancer cases. On account of its rarity, very few prospective clinical trials have been carried out on MBC. Pakistan has the highest incidence of breast...
Tina Chai,Wei Yue,Peng Xu et al.
Tina Chai et al.
Background: The scaffolding protein, caveolin-1 (Cav-1), participates in multiple cellular functions including promotion of sodium excretion from the kidney. Loss of expression of Cav-1 is associated with tumorigenesis of...
Clinical Outcomes of Breast-Conserving Surgery with Synchronous 50-kV X-ray Intraoperative Partial Breast Irradiation in Patients Aged 64 Years or Older with Low-Risk Breast Cancer [0.03%]
低剂量千伏级术中照射结合保乳手术治疗64岁以上低风险乳腺癌患者的临床预后研究
Kamran Salari,Andrew Glaza,Joseph S Lee et al.
Kamran Salari et al.
Background: Breast-conserving surgery with synchronous 50-kV X-ray intraoperative radiation therapy (TARGIT-IORT) is a convenient form of partial breast irradiation; however, the existing literature supports a wide range ...
Sixteen-Year Institutional Review of Magnetic Resonance Imaging-Guided Breast Biopsies: Trends in Histologic Diagnoses With Radiologic Correlation [0.03%]
基于放射学相关的影像导引乳房活检16年回顾：病理诊断趋势分析
Samaneh A Motanagh,Dennis Dwan,Nasim Azizgolshani et al.
Samaneh A Motanagh et al.
Background: Breast magnetic resonance imaging (MRI) is an important imaging tool for the management of breast cancer patients and for screening women at high risk for breast cancer. ...
Are We Prepared for the CDK4/6 Revolution With HR+/HER2- Breast Cancers?: The Importance of Patient Adherence to Adjuvant Therapies [0.03%]
我们准备好迎接CDK4/6抑制剂在HR阳性/HER2阴性乳腺癌中的革命了吗？：患者辅助治疗依从性的的重要性
Seyla Azoz,Martin Peters,Graham Jones
Seyla Azoz
Assessment of Pathological Complete Response Using Vacuum-Assisted Biopsy in Breast Cancer Patients Who Have Clinical and Radiological Complete Response After Neo-Adjuvant Chemotherapy [0.03%]
新辅助化疗后临床和影像学完全缓解的乳腺癌患者中评估病理完全缓解的方法：使用真空辅助活检法
Siddhant Khare,Irrinki Santosh,Ishita Laroiya et al.
Siddhant Khare et al.
Background: Any treatment protocol that leads to complete elimination of surgery may lead to a better patient acceptance of breast cancer treatments. Obje...